IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma
- 1 July 1994
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 43 (3) , 222-227
- https://doi.org/10.1002/jmv.1890430305
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Use of antigen expressed in bacteria for detection of EBV-specific thymidine kinase antibodies in sera from patients with nasopharyngeal carcinomaJournal of Medical Virology, 1992
- Significance of Specific Epstein‐Barr Virus IgA and Elevated IgG Antibodies to Viral Capsid Antigens in Nasopharyngeal Carcinoma PatientsJournal of Medical Virology, 1986
- Increased incidence of IgA antibodies to the epstein-barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemiaInternational Journal of Cancer, 1986
- Epstein‐Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba, and its value for differential diagnosis of the diseaseInternational Journal of Cancer, 1986
- Epstein-Barr virus induction by a serum factor I. Induction and cooperation with additional inducersVirology, 1982
- Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomasInternational Journal of Cancer, 1979
- Nasopharyngeal carcinoma: Significance of changes in epstein‐barr virus‐related antibody patterns following therapyInternational Journal of Cancer, 1977
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the NasopharynxProceedings of the National Academy of Sciences, 1974
- Nasopharyngeal Carcinoma (NPC)Advances in Cancer Research, 1972